 LOS ANGELES--BUSINESS WIRE--- CDXC CellularHealth--ChromaDex Corp. NASDAQ: CDXC today announced results from the study Combined Metabolic Cofactor Supplementation Reduces Liver Fat in Nonalcoholic Fatty Liver Disease were published on Cell Press Sneak Peek, a preprint publication website for papers under review by Cell Press Journals. The Phase 2 study reported a reduction in liver fat and inflammatory markers in patients with non-alcoholic fatty liver disease NAFLD when receiving a nutritional protocol inclu 